Medical expert of the article
New publications
Why does hair fall out during menopause and what to do about it?
Last updated: 09.09.2026
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
During perimenopause and after menopause, hair may indeed become thinner, sparser, and shed more noticeably, but the cause is usually more complex than simply "not enough estrogen." Hormonal changes can affect the growth cycle and hair thickness, and at this age, female-pattern androgenetic thinning is also more common. Furthermore, sudden, severe hair loss may be telogen effluvium due to stress, illness, weight loss, or iron deficiency, while a receding hairline with eyebrow loss may be a completely different condition: frontal fibrosing alopecia.
Therefore, it's important to evaluate not just the number of hairs in your comb, but the pattern of hair loss. A slow widening of the center parting and a visible crown are more consistent with female-pattern hair loss; sudden, uniform hair loss across the entire scalp indicates telogen effluvium. If the hairline noticeably recedes, eyebrows disappear, or the scalp becomes itchy or sore, it's best to consult a dermatologist immediately, as cicatricial alopecia can irreversibly damage follicles.
Initiating menopausal hormone therapy specifically for hair loss is currently not recommended: there is insufficient evidence to support this indication. If female-pattern hair loss is confirmed, minoxidil has the strongest evidence base among medicinal treatments; treatment for other forms of alopecia is fundamentally different. [1]
Menopause changes hair, but does not create a separate disease called "hormonal hair loss."
The hair follicle is sensitive to the hormonal environment, and the menopausal transition is accompanied by significant fluctuations in estrogen levels and the subsequent cessation of their primary production by the ovaries. A modern review from 2025 links the transition to changes in hair density, diameter, and texture and notes that several different hair disorders are more common after menopause—most notably, female-pattern hair loss, telogen effluvium, and frontal fibrosing alopecia. However, these observations do not allow us to assume that every hair loss is a direct consequence of a drop in estradiol. [2]
The common formula "estrogen levels decline, testosterone begins to destroy hair" is particularly inaccurate. In female-pattern hair loss, genetic and hormonal factors are indeed at play, and sensitive follicles gradually miniaturize: new hairs become thinner and shorter. Moreover, many women with this type of thinning do not have elevated circulating androgen levels. Therefore, the modern term "female pattern hair loss" is more accurate than the concept of a simple "androgen attack." [3]
Menopause likely alters the hormonal context in which hereditary predispositions become more pronounced. The American Academy of Dermatology notes that female-pattern hair loss is particularly common in midlife—in the 40s, 50s, or 60s—and acknowledges the role of hormonal changes after menopause, but emphasizes the hereditary nature of the condition. [4]
In other words, two women of the same age may experience completely different situations. One woman's hair parting gradually widens after menopause due to the miniaturization of her follicles. Another woman's hair suddenly begins to fall out in clumps a few months after a serious illness or intense stress. A third woman's forehead recedes and her eyebrows disappear due to inflammatory cicatricial alopecia. Calling all three conditions "menopausal hair loss" would be medically incorrect.
The most common scenario: the parting gradually widens
Gradual thinning of hair on the center and top of the scalp most often suggests female-pattern hair loss. Typically, the center parting becomes wider, the scalp becomes more visible on the crown, and the ponytail appears less voluminous. The front hairline is often significantly better preserved than in typical male-pattern baldness. [5]
Within the affected areas, follicles become miniaturized. Each follicle begins to produce hair of a smaller diameter, shorter length, and lighter color. So, a woman may not initially notice a large amount of hair loss, but gradually notices a loss of density. This explains the typical complaint: "My hair isn't falling out in clumps, but my parting has become twice as noticeable in two years." [6]
This type of thinning develops slowly—over years and sometimes decades. This is why early diagnosis is crucial: the goal of treatment for progressive hair loss is not only to try to grow new hair but also to preserve the remaining functioning follicles. The American Academy of Dermatology also emphasizes that treatment for female-onset hair loss is most effective when it begins at the first signs. [7]
Suddenly there's a lot of hair in the shower
If hair loss has increased sharply and hair is falling out evenly from the entire head, there is more reason to think about telogen effluvium than about the classic female pattern of thinning.
Telogen effluvium occurs when, following a significant stress event, more follicles than usual simultaneously enter the resting phase and subsequently shed. The British Association of Dermatologists indicates that noticeable shedding often begins approximately three months after the trigger. [8]
Typical triggers include severe illness or high fever, surgery, severe psychological stress, significant weight loss or extreme dieting, certain new medications, and discontinuing certain hormone therapy. Hair loss typically occurs diffusely across the scalp rather than forming one distinct bald spot. [9]
It's precisely in midlife that these factors can easily be mistakenly attributed to menopause. For example, a woman may enter perimenopause, simultaneously experience significant weight loss, undergo surgery, and three months later notice a large amount of hair loss in the shower. The menopausal transition may be part of the overall context, but it's impossible to claim that the hair loss is directly caused by declining estrogen levels in such a situation.
Another caveat: telogen effluvium can coexist with female-patterned hair loss, making previously subtle thinning obvious. BAD explicitly notes that the two conditions can coexist, and an episode of telogen effluvium sometimes first alerts a patient to developing patterned hair loss. [10]
How to distinguish hair loss from gradual thinning
These processes are often confused, although subjectively they look different.
| What's happening | A more typical picture | What is especially important |
|---|---|---|
| Female pattern hair loss | The parting gradually widens, the crown becomes translucent, the hair becomes thinner | The process is chronic and progressive. |
| Telogen effluvium | Suddenly there is significantly more hair when washing and combing, thinning is uniform | There is often a trigger several months before the onset |
| Frontal fibrosing alopecia | The hairline on the forehead and temples recedes, and eyebrows may disappear. | Scarring: Lost follicles may not be restored |
| Alopecia areata | Individual, clearly visible areas of hair loss | This is already a different diagnostic scenario. |
| Fragility of rods | Hair becomes shorter and breaks off, but does not necessarily fall out at the roots. | It is necessary to distinguish between hair damage and follicle disease. |
This comparison helps guide the examination but does not replace a dermatological diagnosis. Female-onset hair loss and telogen effluvium are particularly common. [11]
Why does hair become thinner after menopause?
In female-onset hair loss, the follicle shrinks and the hair it produces changes. As a result, some of the thick terminal hairs are gradually replaced by thinner, shorter hairs. In the early stages, the follicle still exists, which is why treatment can support growth and increase visible density. [12]
A 2025 review specifically focusing on menopause and hair also describes a decrease in hair diameter and density as characteristic changes of the menopausal period. The authors discuss the follicle's estrogen sensitivity and the relative change in androgen influence, but this area still contains significant gaps: the precise molecular mechanisms of female hair thinning are less well understood than popular explanations might suggest. [13]
Therefore, it's impossible to measure estradiol in a specific woman, see a low value, and conclude, "That's the cause of her hair loss." Menopause itself is diagnosed after age 45 primarily clinically, not by a single hormone test; furthermore, such tests do not determine the type of alopecia. [14]
Should I get FSH and estradiol tests due to hair loss?
Usually not, unless a woman is over 45 and the menopausal transition is already obvious based on her age, cycle, and other symptoms.
The European Society of Endocrinology, in its 2025 guidelines, explicitly recommends against the use of routine biochemical testing for the diagnosis or management of perimenopause in women over 45 years of age. Follicle-stimulating hormone levels fluctuate during the transition period, so a normal value does not rule out perimenopause, and an elevated value does not explain the mechanism of hair loss. [15]
It is important to distinguish between two issues here:
"Am I starting perimenopause?"
AND
"Why exactly does hair fall out?"
For the second question, it is much more informative to examine the scalp and assess the nature of the thinning, and, if necessary, to conduct studies of iron, thyroid function, or androgens according to specific indications. [16]
Should I get my testosterone checked?
Not every woman with thinning hair requires a high hormonal profile. Isolated female pattern hair loss alone is a relatively weak predictor of elevated androgen levels, and many women with a characteristic widening parting have normal testosterone levels. [17]
A completely different situation arises when, along with hair loss after menopause, signs of excess androgen activity quickly appear: noticeably increased growth of coarse hair on the face or body, severe acne, a deepening of the voice, or the development of other signs of virilization. The rapid onset and progression after menopause are particularly alarming. [18]
The Society for Endocrinology's current guidelines for androgen excess in women indicate that the late and rapidly progressive onset of virilizing symptoms requires a more aggressive search for the cause, including rare androgen-producing tumors of the ovaries or adrenal glands. In such situations, targeted hormonal testing is performed, and in cases of significant biochemical abnormalities, imaging is also performed. [19]
This isn't a reason to look for a tumor in every woman with a widened parting. The main symptom that changes tactics is a new, rapidly progressing hyperandrogen pattern, rather than the usual slow, age-related thinning.
Iron and Thyroid: When They Really Matter
Iron deficiency and thyroid dysfunction are real alternative causes of diffuse hair loss, so they are often considered when telogen effluvium is suspected. The British Association of Dermatologists specifically states that blood tests can be used to rule out iron deficiency and thyroid disease in this type of hair loss. [20]
It's especially logical to check a complete blood count and iron levels if, during perimenopause, periods become very heavy, diet is restricted, or weakness and decreased exercise tolerance occur simultaneously. In this situation, hair loss may coincide with the menopause transition, but the immediate problem will be iron deficiency.
Thyroid function is considered when diffuse hair loss is accompanied by other clinical signs or when the cause remains unclear. A review of hormonal factors in alopecia also confirms the association of thyroid dysfunction with several common forms of hair loss. [21]
However, the idea that "the higher the ferritin, the thicker the hair" doesn't have a simple, universally proven threshold for all women. Don't self-administer large doses of iron just to boost your lab results—you first need to confirm the deficiency and understand its cause.
Vitamin D, zinc, biotin: should you get everything tested?
Routine use of hair supplements without a known deficiency is not recommended.
The American Academy of Dermatology advises using iron, zinc, or biotin when laboratory data does confirm a deficiency; excess of some nutrients can also cause harm.[22]
This is especially relevant for menopause, which is the focus of a large market for "hair + hormones" combinations. The presence of the word "menopause" on the packaging does not prove that the product promotes hair follicle miniaturization or treats telogen effluvium.
If the diet is varied and there are no laboratory signs of deficiency, supplements do not replace diagnosis of the type of alopecia.
If your hairline is receding, it shouldn't be automatically assumed to be normal aging.
A receding frontal-temporal hairline along with eyebrow loss is one of the most important signs to differentiate from the usual female pattern of hair loss.
Frontal fibrosing alopecia is an inflammatory scarring alopecia in which immune inflammation damages and destroys hair follicles. Once the follicle is destroyed, hair loss becomes permanent. The American Academy of Dermatology therefore emphasizes the benefits of early diagnosis and treatment to slow the further spread of the disease. [23]
The typical pattern is a gradual receding of the hairline from the forehead and temples, sometimes forming a band of lighter, smoother skin. Loss of the outer eyebrows may occur even earlier. Some people experience itching, soreness, or small inflammatory lesions along the hairline. [24]
Most diagnosed patients are postmenopausal women, although the disease can occur earlier. A recent systematic review of menopausal dermatoses also found a particularly strong postmenopausal association for frontal fibrosing alopecia and female-pattern hair loss. [25]
The association with menopause does not mean that the condition is simply caused by a lack of estrogen. The cause of frontal fibrosing alopecia remains unclear; a combination of immune, genetic, and hormonal factors is considered. [26]
What signs require an earlier consultation with a dermatologist?
While a normal, gradual widening of the parting is not an emergency, there are several situations in which delaying diagnosis is particularly undesirable.
If the hairline is rapidly receding from the forehead, eyebrows are falling out, the scalp is painful or itchy, and redness or flaking appears around the follicles, cicatricial alopecia should be ruled out. Follicles lost in such conditions are significantly more difficult to restore, so the goal of treatment is to stop active inflammation before further damage occurs. [27]
A more active evaluation is also needed in cases of sudden onset of smooth, hairless patches, very rapid overall thinning, or hair loss in other areas of the body. These signs do not fit well with the usual slowly progressive female patterned hair loss. [28]
A separate scenario is rapid hair thinning after menopause, along with increasing hirsutism, severe acne, or signs of virilization. This combination requires testing for pathological androgen excess. [29]
How does a dermatologist determine the cause?
The diagnosis starts with the pattern of prolapse, not with a long list of tests.
For female-type hair loss, the doctor evaluates the gradual progression of the process, the location of thinning, family history, and the condition of the scalp. The British Association of Dermatologists notes that the diagnosis is usually established by the characteristic history and distribution of hair loss; if the picture is unclear, a scalp biopsy is sometimes required. [30]
Trichoscopy—a dermatoscopic examination of hair and scalp under magnification—is very useful. In patterned hair loss, it helps identify differences in hair diameter and miniaturization, and in inflammatory cicatricial forms, it reveals signs of damage to areas around the follicles. Modern reviews of female androgenetic alopecia include trichoscopy as a core diagnostic tool. [31]
In cases of severe diffuse hair loss, the doctor also looks for a possible trigger several months ago: illness, surgery, weight loss, severe stress, or a change in medication or hormonal therapy. If necessary, a gentle hair pull test is performed, and laboratory tests are selected based on the clinical situation. [32]
Not every patient requires a biopsy. It becomes especially useful when the clinical and trichoscopic findings do not allow for a confident distinction between non-scarring and scarring alopecia. [33]
What tests can actually be helpful?
There is no one-size-fits-all "menopause hair loss checklist."
| Study | When is it especially useful? | What it doesn't prove |
|---|---|---|
| Examination and trichoscopy | For almost any persistent thinning | It is not always possible to avoid a biopsy |
| Complete blood count | Suspected anemia, blood loss | Normal hemoglobin does not explain the type of alopecia |
| Ferritin/iron metabolism | Diffuse loss, heavy bleeding, risk of deficiency | A low number alone does not prove that all hair loss is caused by iron. |
| Thyroid-stimulating hormone | Suspected thyroid dysfunction or unexplained diffuse loss | Does not diagnose female type of hair loss |
| Androgens | Rapid hyperandrogenic picture, hirsutism, virilization | Not needed as an explanation for every extended parting |
| Scalp biopsy | Suspected cicatricial alopecia or unclear picture | Not every woman's first test |
This selective approach is more consistent with modern dermatological practice than commercial kits of dozens of vitamins and hormones.
What to do about female-pattern hair loss
The most proven treatment option is topical minoxidil. A recent review of FPHL therapy lists it as the drug with the highest level of evidence and the first-line treatment. The British Association of Dermatologists and the American Academy of Dermatology also consider minoxidil a primary treatment option.
It doesn't work within a few weeks. The first few months are needed to change the follicle cycle, and noticeable results are assessed much later. At the beginning of treatment, a temporary increase in hair loss is possible, after which it usually subsides. To maintain the achieved effect, the drug must be continued; after its discontinuation, the benefits gradually fade. [34]
There is also an important international difference. In the US, the American Academy of Dermatology lists 2% and 5% minoxidil concentrations as approved for women. In the UK, the BAD describes the 2% concentration as the licensed concentration for women, while use of the 5% solution may be on the advice of a healthcare professional. Therefore, it is wise to check the specific concentration and dosage with the product label and the regulations of the specific country. [35]
What about oral minoxidil?
Low-dose oral minoxidil is increasingly used by dermatologists, but for alopecia, it is an off-label treatment and not the equivalent of a typical over-the-counter topical treatment.
The 2025 International Delphi Consensus was developed by 43 hair disease specialists from 12 countries specifically because low-dose oral minoxidil is actively used for various alopecias, but large, standardized studies and uniform, official regimens are still lacking. The consensus covered indications, contraindications, baseline assessment, and monitoring, but the authors themselves emphasize the need for further comparative studies and long-term data. DOI: 10.1001/jamadermatol.2024.4593. [36]
The drug is primarily a systemic vasodilator, so the decision to prescribe it depends on blood pressure, cardiovascular history, and other factors. It is not an option for self-administering topical minoxidil tablets.
A 2025 review by the American Academy of Dermatology also emphasizes that topical minoxidil remains an approved treatment for androgenetic alopecia, while the low-dose oral version is used off-label and requires an informed approach to safety. DOI: 10.1016/j.jaad.2025.04.016. [37]
When spironolactone, finasteride, or dutasteride are used
These drugs are sometimes used in women with patterned hair loss, especially in specific clinical situations, but their place and regulatory status differ from minoxidil.
The BAD lists spironolactone and other antiandrogen medications as possible systemic options, while noting that they are not licensed in the UK specifically for FPHL. The American Academy of Dermatology also lists spironolactone, finasteride, and dutasteride as prescription options that dermatologists can use off-label. [38]
The reproductive context is especially important. A perimenopausal woman can still become pregnant, so medications that pose a risk to the developing fetus require reliable contraception or are not suitable at all. The Dietary Supplement (BSI) and the American Academy of Nutrition (AAD) specifically warn of such restrictions. [39]
Once natural menopause has been confirmed, pregnancy is no longer a concern, but other medical contraindications and side effects remain. Therefore, systemic treatment is chosen based on diagnosis, rather than the principle that "everyone over 50 needs an antiandrogen."
Does hormone therapy help restore hair?
Menopausal hormone therapy is no longer considered a treatment to be started simply because of hair loss.
A 2026 review specifically focusing on hormone therapy and hair during perimenopause and menopause concludes that menopausal hormone therapy is not indicated for the treatment of hair loss as a standalone problem. If a woman has common indications for hormone therapy—for example, clinically significant menopausal symptoms—its use should be considered separately. [40]
This is an important distinction from the popular promises of "returning estrogen will restore hair thickness." The follicle is indeed a hormone-sensitive system, but there is insufficient evidence to support the use of systemic estrogen as a standard treatment for FPHL or telogen effluvium.
Furthermore, a 2025 systematic review of dermatological conditions in menopause found that evidence on the effects of menopausal hormone therapy on various alopecias is heterogeneous and largely based on older hormone therapy regimens that are less commonly used today.[41]
Therefore, hair treatment and treatment of menopausal symptoms should be considered as related but not identical tasks.
What to do if you have telogen effluvium
If the cause is telogen effluvium, the main treatment is to find and correct the trigger, and in many cases the hair gradually regrows on its own.
The British Association of Dermatologists notes that the active phase of increased hair loss typically lasts several months, after which new hair growth begins; restoration of previous volume takes longer. A specific medication capable of immediately accelerating this natural process is usually not required. [42]
For example, if severe iron deficiency is the cause, it needs to be treated. If hair loss began after extreme calorie restriction and rapid weight loss, a balanced diet needs to be restored. If a serious illness was the trigger, time is needed for the follicular cycle to normalize.
However, if intense hair loss lasts for more than six months or if widening of the parting becomes evident at the same time, the doctor will reconsider the diagnosis and consider chronic telogen effluvium or a combination with FPHL. [43]
Will plasma therapy, mesotherapy or laser help?
The evidence base for adjunctive treatments is mixed and generally weaker than that for minoxidil.
The British Association of Dermatologists notes that there is insufficient data on platelet-rich plasma in female pattern hair loss to determine with certainty who benefits from it and under what regimen.[44]
The American Academy of Dermatology allows the use of some laser devices as an adjunctive approach, but emphasizes that the long-term effectiveness of newer at-home technologies is less well-studied.[45]
Therefore, mesotherapy, plasma therapy, or hardware-based procedures should not replace a diagnosis. It is especially undesirable to stimulate "hair growth" for months in cases of undiagnosed cicatricial alopecia, where the primary goal is to stop the inflammatory destruction of the follicle.
Can hair care stop hair loss?
Shampoo and cosmetic masks are not able to eliminate the miniaturization of follicles in FPHL, but proper care reduces breakage and additional mechanical damage to already thinning hair.
BAD recommends that in cases of severe telogen effluvium, avoid rough brushing, frequent, intense use of hot tools, aggressive bleaching and chemical treatments, and tight hairstyles. [46]
This isn't a treatment for the hormonal mechanism, but rather a protection for the remaining hair. If hair has become drier and more brittle after menopause, reducing thermal and chemical damage can improve its appearance, even if follicle density itself remains unchanged.
Why Rapid Weight Loss Can Make Things Worse
Significant weight loss and extreme dieting are known triggers for telogen effluvium. However, increased hair loss may not begin immediately, but rather months later, when the causative event seems forgotten. [47]
This is especially true in middle age, when women often simultaneously try to dramatically lose weight gained during menopause. Weight loss alone doesn't necessarily mean hair loss, but severe energy restriction or inadequate protein and micronutrient intake can disrupt the growth cycle.
Therefore, a rational weight loss strategy should take into account not only the number on the scale, but also the completeness of the diet.
What's happening to the eyebrows?
Minor age-related thinning of eyebrows is possible, but significant or progressive loss of the outer portions of the eyebrows, along with a receding hairline, requires attention.
In frontal fibrosing alopecia, eyebrow loss is a very characteristic feature and may appear before noticeable frontal balding.[48]
If hair loss affects not only the scalp but also the eyelashes or other areas of the body, other types of alopecia, including alopecia areata, should also be considered.[49]
This is why photographs of the old hairline and eyebrows are sometimes much more useful to a dermatologist than another estradiol test.
Is it possible to restore the previous density completely?
The answer depends on the diagnosis.
With telogen effluvium, if the trigger is removed and the follicles are not damaged, hair usually begins to grow back and gradually regains volume, although this process takes months.[50]
In female hair loss, the condition is chronic. Modern methods can slow the progression and, in some women, increase density, but it is not always possible to fully restore the density of youth. BAD explicitly characterizes FPHL as a slowly progressive condition for which there is no definitive cure, although treatment can improve the situation. [51]
In frontal fibrosing alopecia, follicles already destroyed by the scarring process typically do not regrow. Therefore, early stabilization of the process is especially valuable here, rather than waiting for spontaneous regrowth. [52]
A practical guide to what to do if hair loss occurs during menopause.
If hair loss is slow and the main symptom is a widening parting, it's wise to consult a dermatologist, preferably one with experience treating hair disorders. Early diagnosis of FPHL allows for treatment to begin before significant miniaturization occurs. [53]
If hair loss suddenly begins to increase significantly across your entire head, consider events in the past few months: a serious illness, surgery, severe stress, rapid weight loss, or a change in medication or hormonal treatment. Your doctor may also evaluate your iron and thyroid function if necessary. [54]
If your forehead is receding, your eyebrows are disappearing, or your scalp is itchy or painful, it is best to consult a dermatologist as soon as possible due to the risk of cicatricial alopecia. [55]
If hair loss progresses rapidly along with new, pronounced facial hair growth, acne, or virilization after menopause, a targeted evaluation for androgen excess is needed.[56]
And if the diagnosis is already established as FPHL, the most evidence-based initial drug approach remains minoxidil; systemic drugs and procedures are considered individually. [57]
What is often misunderstood
"After menopause, hair loss occurs solely due to the decline in estrogen." Hormonal transitions affect hair, but at this age, FPHL, telogen effluvium, and cicatricial alopecia are all common. Therefore, a single mechanism does not explain all cases. [58]
"If female hormone tests are negative, the diagnosis is already clear." After 45 years, menopause is usually diagnosed clinically, and FSH and estradiol do not determine the type of alopecia. [59]
"It is imperative to increase ferritin as much as possible." Iron deficiency can indeed accompany diffuse hair loss, but iron should be prescribed when the deficiency is confirmed, and not to achieve an arbitrary "trichological" figure. [60]
"Biotin is beneficial for all women over 50." No. The AAD recommends supplements like biotin, iron, and zinc for identified deficiencies, not as a universal treatment for hair loss. [61]
"Hormone therapy will bring back hair." Currently, menopausal hormone therapy is not indicated solely for the treatment of hair loss. [62]
"If your hair is receding on your forehead, it's just age." Not necessarily. A receding hairline, along with loss of eyebrows, may indicate frontal fibrosing alopecia, a scarring condition for which early treatment is especially important. [63]
Key points from experts
Bianca Maria Piraccini is a professor of dermatology at the University of Bologna and director of the School of Specialization in Dermatology and Venereology. Her research focuses specifically on hair and nail diseases, including androgenetic alopecia and frontal fibrosing alopecia. The University of Bologna confirms that her group is involved in the diagnosis and treatment of alopecias and the study of frontal fibrosing alopecia. [64]
Piraccini was a participant in the 2025 international consensus on low-dose oral minoxidil. The consensus authors note that this off-label approach is already widely used by specialists, but comparative studies, long-term safety, and standardization of use still require additional data. [65]
Paradi Mirmirani, MD, FAAD, is a dermatologist specializing in hair disorders, regional director of hair disorders at The Permanente Medical Group, and a clinical instructor at the University of California, San Francisco. Her professional profile reflects her long-standing specialization in the diagnosis and treatment of hair disorders. [66]
Mirmirani also served on an international expert group on oral minoxidil. The group's position is particularly useful for patients with menopausal hair loss: oral minoxidil should not be considered a regular tablet version of a topical treatment—it is an off-label therapy that requires an assessment of contraindications, risks, and monitoring. [67]
Shoshana Marmon, MD, PhD, is a dermatologist at NYC Health + Hospitals and Assistant Professor of Dermatology at New York Medical College. Her academic credentials include a specialization in dermatology and MD/PhD training. [68]
Marmon was the senior author of a systematic review of estrogen therapy for menopausal hair loss published in 2026. Current reviews in this area reflect a major current uncertainty: the biological role of estrogens in the follicle is plausible, but clinical data are insufficient to support the use of menopausal hormone therapy specifically for the treatment of alopecia. [69]
Frequently Asked Questions
Is it normal for hair to become thinner after 50?
While this is common, significant hair thinning shouldn't be considered an inevitable part of aging. Female-onset hair loss often becomes noticeable in the 50s and 60s and is treatable, especially if started early. [70]
Why has the parting become much wider?
The most common explanation is the miniaturization of hair in female-pattern hair loss. Hair on the top of the head becomes increasingly thinner, causing the central parting to appear wider. [71]
Why did my hair suddenly start falling out in clumps?
Sudden diffuse hair loss is more reminiscent of telogen effluvium. It can begin several months after an illness, surgery, severe stress, rapid weight loss, or a change in medication therapy. [72]
Can menopause cause telogen effluvium?
Hormonal changes can affect the hair cycle, but if telogen effluvium is severe, other triggers should be sought. The mere coincidence with menopause does not prove a single cause. [73]
Should you count your hair loss every day?
No. It's more useful to monitor changes in hair volume, parting width, and hair loss patterns, and take photos under similar conditions. Hair count naturally fluctuates, and an accurate daily count rarely provides a diagnosis.
Should I have an FSH test because of hair loss?
After 45 years - usually not, if the menopausal transition is already clinically obvious. FSH does not reveal the cause of alopecia. [74]
Should I get my ferritin checked?
In diffuse hair loss, especially if there is a risk of iron deficiency or heavy bleeding, this often makes sense. However, iron supplementation should be considered after the deficiency has been confirmed. [75]
Should I get my testosterone tested?
Not for every woman. Hormonal assessment becomes especially important in cases of rapid hair loss progression along with hirsutism, severe acne, or signs of virilization. [76]
Can minoxidil increase hair loss at first?
Yes. Shedding may temporarily increase during the first few weeks, after which it usually decreases. The effect is assessed over months, not just a few weeks. [77]
If minoxidil helps, can it be stopped later?
In female hair loss, the effect is maintained as long as treatment is continued. After discontinuation, the achieved benefit is gradually lost. [78]
Is minoxidil tablet more effective than topical minoxidil?
Low-dose oral minoxidil has a promising evidence base, but direct comparative data and long-term standardization are still lacking. It is used off-label and requires medical supervision. [79]
Will hormonal therapy help with hair loss?
It shouldn't be started just for hair. If hormone therapy is needed for common menopausal indications, its effect on hair can be discussed separately, but hair loss itself is not currently an established indication. [80]
Will biotin help?
Only if there is a real deficiency. Taking biotin for menopausal hair loss is not recommended. [81]
Why do eyebrows thin at the same time?
If the eyebrows are noticeably disappearing along with the receding frontal hairline, frontal fibrosing alopecia must be ruled out.[82]
Can hair grow back after menopause?
It depends on the cause. With telogen effluvium, recovery is often good; with FPHL, treatment can slow progression and increase density; with cicatricial alopecia, damaged follicles usually do not regrow.
Main
Menopause can indeed coincide with a noticeable change in hair thickness and texture, but "menopausal hair loss" is not a single diagnosis. The most common chronic pattern is female-pattern hair loss, with a gradual widening of the parting and hair thinning. Sudden, uniform hair loss prompts a search for telogen effluvium and its trigger, while a receding frontal line, along with eyebrow loss, necessitates the exclusion of cicatricial frontal fibrosing alopecia.
For this reason, it's more useful to begin with a dermatological diagnosis of the type of hair loss rather than a comprehensive hormonal profile and vitamin supplementation. After age 45, FSH and estradiol are usually not needed to confirm menopause, whereas with diffuse hair loss, iron and thyroid function tests may be relevant, and with new, rapidly progressing virilization, targeted androgen testing may be necessary.
For confirmed female pattern hair loss, minoxidil remains the most proven first-line treatment. Hormonal therapy should not be initiated solely for hair restoration, and supplements are beneficial primarily if a deficiency has been confirmed.

